HRAS and urinary bladder carcinoma: However, although mutation of HRAS as well as FGFR3 and PI3K/AKT/mTOR components are associated with development of noninvasive bladder cancer, it is unknown if the hyperplastic and/or transformed state depends upon maintenance of oncogene expression.